574 related articles for article (PubMed ID: 8073287)
1. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
2. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
[TBL] [Abstract][Full Text] [Related]
3. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
4. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
6. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
7. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin and the humoral regulation of thrombocytopoiesis.
Eaton DL; de Sauvage FJ
Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990
[TBL] [Abstract][Full Text] [Related]
10. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
11. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
12. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
14. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
[TBL] [Abstract][Full Text] [Related]
15. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
16. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Krukemeier S; Welte K
Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
Alexander WS
Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocyte development and platelet production.
Deutsch VR; Tomer A
Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
